Fulgent Genetics (FLGT) News Today

$22.11
-0.39 (-1.73%)
(As of 05/17/2024 ET)
Fulgent Genetics (NASDAQ:FLGT) Stock Price Up 5.5%
Fulgent Genetics (NASDAQ:FLGT) Trading 5.5% Higher
Q1 2024 Fulgent Genetics Inc Earnings Call
Fulgent Genetics (NASDAQ:FLGT) Releases FY 2024 Earnings Guidance
Fulgent Genetics (NASDAQ:FLGT) updated its FY 2024 earnings guidance. The company provided EPS guidance of -1.050--1.050 for the period, compared to the consensus estimate of -1.060. The company also issued revenue guidance of $280.0 millionillion-$280.0 millionillion, compared to the consensus estimate of $279.4 millionillion.
Mirae Asset Global Investments Co. Ltd. Trims Stock Position in Fulgent Genetics, Inc. (NASDAQ:FLGT)
Mirae Asset Global Investments Co. Ltd. lowered its position in Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) by 57.6% in the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 43,794 shares of the company's stock after selling 59,588 shares du
Fulgent Genetics Inc FLGT
Fulgent Genetics (NASDAQ:FLGT) Reaches New 12-Month Low at $20.32
Fulgent Genetics (NASDAQ:FLGT) Hits New 52-Week Low at $20.32
Fulgent Genetics (NASDAQ:FLGT) Sets New 52-Week Low at $20.66
Fulgent Genetics (NASDAQ:FLGT) Reaches New 52-Week Low at $20.66
Fulgent Genetics (NASDAQ:FLGT) Reaches New 1-Year Low at $21.20
Fulgent Genetics (NASDAQ:FLGT) Sets New 52-Week Low at $21.20
Fulgent Genetics, Inc. (NASDAQ:FLGT) Short Interest Up 22.6% in March
Fulgent Genetics, Inc. (NASDAQ:FLGT - Get Free Report) was the recipient of a large increase in short interest during the month of March. As of March 15th, there was short interest totalling 611,200 shares, an increase of 22.6% from the February 29th total of 498,400 shares. Approximately 3.2% of the company's shares are short sold. Based on an average daily trading volume, of 208,900 shares, the short-interest ratio is currently 2.9 days.
Fulgent Genetics (NASDAQ:FLGT) Hits New 1-Year Low at $21.26
Fulgent Genetics (NASDAQ:FLGT) Reaches New 1-Year Low at $21.26
FLGT Apr 2024 20.000 call
Fulgent Genetics (NASDAQ:FLGT) Sets New 1-Year Low at $22.25
Fulgent Genetics (NASDAQ:FLGT) Hits New 12-Month Low at $22.25
Invesco Ltd. Has $8.36 Million Stock Holdings in Fulgent Genetics, Inc. (NASDAQ:FLGT)
Invesco Ltd. raised its stake in Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) by 150.3% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 312,627 shares of the company's stock after acquiring an add
Fulgent Genetics (NASDAQ:FLGT) PT Lowered to $25.00 at Piper Sandler
Piper Sandler lowered their target price on shares of Fulgent Genetics from $28.00 to $25.00 and set a "neutral" rating for the company in a report on Wednesday.
Q4 2023 Fulgent Genetics Inc Earnings Call
Here's what to expect from Fulgent Genetics's earnings report
Fulgent Genetics (NASDAQ:FLGT) Updates FY 2024 Earnings Guidance
Fulgent Genetics (NASDAQ:FLGT) updated its FY 2024 earnings guidance. The company provided EPS guidance of -1.050--1.050 for the period, compared to the consensus estimate of -0.950. The company also issued revenue guidance of $280.0 millionillion-$280.0 millionillion, compared to the consensus estimate of $294.2 millionillion.
Brandywine Global Investment Management LLC Invests $2.43 Million in Fulgent Genetics, Inc. (NASDAQ:FLGT)
Brandywine Global Investment Management LLC acquired a new position in Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 90,867 shares of the company
FLGT Mar 2024 30.000 call
FLGT Mar 2024 35.000 put
Campbell & CO Investment Adviser LLC Acquires 42,495 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT)
Campbell & CO Investment Adviser LLC raised its holdings in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) by 461.7% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 51,700 share
Fulgent Genetics, Inc. (NASDAQ:FLGT) Sees Significant Decrease in Short Interest
Fulgent Genetics, Inc. (NASDAQ:FLGT - Get Free Report) saw a significant decrease in short interest in December. As of December 31st, there was short interest totalling 551,900 shares, a decrease of 15.0% from the December 15th total of 649,400 shares. Currently, 2.9% of the shares of the stock are sold short. Based on an average daily trading volume, of 217,600 shares, the short-interest ratio is currently 2.5 days.
Trellus Management Company LLC Makes New $1.15 Million Investment in Fulgent Genetics, Inc. (NASDAQ:FLGT)
Trellus Management Company LLC bought a new position in Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 43,100 shares of the company's stock, v
Trellus Management Company LLC Makes New $1.15 Million Investment in Fulgent Genetics, Inc. (NASDAQ:FLGT)
Trellus Management Company LLC bought a new position in Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 43,100 shares of the company's stock, v
Following Up On Fulgent Genetics
Get Fulgent Genetics News Delivered to You Automatically

Sign up to receive the latest news and ratings for FLGT and its competitors with MarketBeat's FREE daily newsletter.

CEO of Biggest AI Chipmaker Just Dropped a Bombshell… (Ad)

Nvidia’s CEO calls it the “next amazing revolution” … and even declared it “is going to be flat out of the biggest [revolution] ever.” Jeff Bezos, Bill Gates, and Mark Zuckerberg have invested billions in it.

Click on Adam's shiny forehead for more details.

FLGT Media Mentions By Week

FLGT Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

FLGT
News Sentiment

-0.12

0.42

Average
Medical
News Sentiment

FLGT News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

FLGT Articles
This Week

1

1

FLGT Articles
Average Week

Get Fulgent Genetics News Delivered to You Automatically

Sign up to receive the latest news and ratings for FLGT and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:FLGT) was last updated on 5/19/2024 by MarketBeat.com Staff

From Our Partners